Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Davide Ruggero(University of California, San Francisco), Oded Meyuhas(Hebrew University of Jerusalem), Cole Davis(University of California, San Francisco), Ornella Zollo(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Maria Da Costa(University of California, San Francisco), Morris E. Feldman(Weizmann Institute of Science), Joseph R. Testa(Fox Chase Cancer Center)
Cited by 463
Related Papers
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
|Science|2018|4.4k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k